P53 mutations may explain the decreased survival in the activated B-like subgroup of diffuse large B-cell lymphomas

被引：0
|
作者：
Greiner, TC
Farrell, BT
Weisenburger, DD
Hoeck, L
Armitage, JO
Staudt, L
Chan, WC
机构：
[1] Univ Nebraska, Med Ctr, Omaha, NE USA
[2] NCI, Bethesda, MD 20892 USA
来源：
LABORATORY INVESTIGATION | 2002年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1011
引用
收藏
页码：242A / 242A
页数：1
相关论文
共 50 条
  • [21] Treatment of Diffuse Large B-Cell Lymphomas
    Magomedova, Aminat U.
    Kravchenko, Sergey K.
    Kremenetskaya, Alexandra
    Zvonkov, Evgenyi
    Baryakh, Elena
    Mangasarova, Yana
    Kaplanskaya, Irina
    Samojlova, Rima
    Vorobjev, Ivan A.
    Obuchova, Tatjana
    Karagjuljan, Suren
    Klyasova, Galina
    Shulutko, Elena
    Galstyan, Gennadii
    Marjin, Dmitrii
    Gabeeva, Nelya
    Vorobjev, Andrey
    BLOOD, 2011, 118 (21) : 1153 - 1154
  • [22] Treatment of diffuse large B-cell lymphomas
    Zwick, C.
    Murawski, N.
    Pfreundschuh, M.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (03) : 150 - 153
  • [23] Everolimus in diffuse large B-cell lymphomas
    Merli, Michele
    Ferrario, Andrea
    Maffioli, Margherita
    Arcaini, Luca
    Passamonti, Francesco
    FUTURE ONCOLOGY, 2015, 11 (03) : 373 - 383
  • [24] Treatment of diffuse large B-cell lymphomas
    Fisher, Richard I.
    SEMINARS IN HEMATOLOGY, 2006, 43 (04) : 205 - 206
  • [25] p37Ing1b Regulates B-Cell Proliferation and Cooperates with p53 to Suppress Diffuse Large B-Cell Lymphomagenesis
    Coles, Andrew H.
    Marfella, Concetta G. A.
    Imbalzano, Anthony N.
    Steinman, Heather A.
    Garlick, David S.
    Gerstein, Rachel M.
    Jones, Stephen N.
    CANCER RESEARCH, 2008, 68 (21) : 8705 - 8714
  • [26] p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status
    Richardson, Aida Ibricevic
    Zhang, Da
    Woodroof, Janet
    Cui, Wei
    HUMAN PATHOLOGY, 2019, 86 : 21 - 31
  • [27] Integrative Analysis Reveals Multiple Alterations of p53 Signaling Pathway Components In Primary Diffuse Large B-Cell Lymphomas
    Chapuy, Bjoern
    Monti, Stefano
    Takeyama, Kunihiko
    Getz, Gad
    Rodig, Scott J.
    Kutok, Jeffery
    Golub, Todd R.
    Shipp, Margaret A.
    BLOOD, 2010, 116 (21) : 279 - 279
  • [28] The significance of P53 and Bcl-2 protein expression in patients with primary gastrointestinal diffuse large B-cell lymphomas
    Cakmak, Erol
    Eser, Bulent
    Sari, Ismail
    Altuntas, Fevzi
    Canoz, Ozlem
    Ozkan, Metin
    Er, Ozlem
    Cetin, Mustafa
    Unal, Ali
    ANNALS OF ONCOLOGY, 2004, 15 : 162 - 162
  • [29] B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas
    Bai, M
    Skyrlas, A
    Agnantis, NJ
    Kamina, S
    Papoudou-Bai, A
    Kitsoulis, P
    Kanavaros, P
    ANTICANCER RESEARCH, 2005, 25 (1A) : 347 - 362
  • [30] p53 gene mutations are associated with rapid progression and poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.: A gela study.
    Leroy, K
    Haioun, C
    Lapage, E
    Le Métayer, N
    Berger, F
    Labouyrie, E
    Duval, C
    Meignin, V
    Petit, B
    Bastard, C
    Salles, G
    Gisselbrecht, C
    Reyes, F
    Gaulard, P
    BLOOD, 1999, 94 (10) : 699A - 699A
12345